Overview

Full Product Details

Author:   Rossen Donev (Head of Research, MicroPharm Limited, UK) ,  Rossen Delete Donev (Swansea University, UK) ,  Rossen Delete Donev (Swansea University, UK) ,  Rossen Delete Donev (Swansea University, UK)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Academic Press Inc
Volume:   99
Dimensions:   Width: 15.20cm , Height: 1.50cm , Length: 22.90cm
Weight:   0.390kg
ISBN:  

9780128028278

ISBN 10:   0128028270
Pages:   192
Publication Date:   05 June 2015
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Peptide Immunotherapy in Vaccine Development: from Epitope to Adjuvant Hyun Yang and Dong Seok Kim The use of liposomes to shape epitope structure and modulate immunogenic responses of peptide vaccines against HIV MPER. Beatriz Apellániz and José L. Nieva Recombinant Lipoproteins as Novel Vaccines with Intrinsic Adjuvant Pele Chong, Jui-Hsin Huang, Chih-Hsiang Leng, Shih-Jen Liu and Hsin-Wei Chen Chemical Platforms for Peptide Vaccine Constructs Suhas Ramesh, Prabhakar Cherkupally, Thavendran Govender, Hendrik G. Kruger, Fernando Albericio and Beatriz G. de la Torre Understanding Amino Acid Mutations in Hepatitis B Virus Proteins for Rational Design of Vaccines and Drugs Ke Shen, Li Shen, Jing Wang, Zhi Jiang and Bairong Shens Perspective of peptide vaccine composed of epitope peptide, CpG-DNA, and liposome complex without carriers Younghee Lee, Young Seek Lee, Sooyoung Cho and Hyung-Joo Kwon

Reviews

Author Information

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions